Exchange: NYSE·Updated 04:16 PM EDT
ADCT logo

ADCT Adc Therapeutics SA

$1.33
$0.08
(6.45%)
Today
Closed $1.32
$0.01
(0.76%)
After Hours
Reported EarningsAug 13
Mkt Cap$158.31M
Vol1.95M

About ADCT

ADC Therapeutics SA is a clinical-stage biotechnology company, which engages in the research and development and commercialization of targeted antibody drug conjugates for patients with hematological malignancies and solid tumors. Its clinical-stage product candidates include loncastuximab tesirine, camidanlumab tesirine, and ADCT-602. The company was founded by Christopher Martin on June 6, 2011 and is headquartered in Epalinges, Switzerland.
50

Neutral Sentiment

How do you feel about ADCT?

Advertisement|Remove ads.